Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,977 public trials 2,028 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Combination of SAR3419 and Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

NCT01470456

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Investigational Site Number 040002 Graz, Austria
  • Investigational Site Number 250004 Créteil, France
  • Investigational Site Number 250009 Dijon, France
  • Investigational Site Number 250006 Lille, France
View all 13 locations
View Trial Details
Completed

Combination Chemotherapy With or Without Bortezomib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

NCT00513955

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Basingstoke and North Hampshire NHS Foundation Trust Basingstoke, England, United Kingdom
  • Good Hope Hospital Birmingham, England, United Kingdom
  • Birmingham Heartlands Hospital Birmingham, England, United Kingdom
  • Blackpool Victoria Hospital Blackpool, England, United Kingdom
View all 25 locations
View Trial Details
Completed

Bendamustine Hydrochloride in Combination With Rituximab in Patients With Relapsed Refractory Mantle Cell Lymphoma

NCT00891839

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Teva Investigational Site 11 Fountain Valley, California, United States
  • Teva Investigational Site 2 Los Angeles, California, United States
  • Teva Investigational Site 35 Orlando, Florida, United States
  • Teva Investigational Site 30 Lafayette, Indiana, United States
View all 13 locations
View Trial Details
Completed

Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML

NCT00123487

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +19 more
Locations
  • University Of Alabama At Birmingham Birmingham, Alabama, United States
  • Loma Linda University Cancer Center Loma Linda, California, United States
  • Ucla Dept. Of Medicine Los Angeles, California, United States
  • Washington Cancer Institute At Washington Hospital Center Washington D.C., District of Columbia, United States
View all 119 locations
View Trial Details

Related conditions